Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

MAPK/ERK Pathway

7 Items

per page
  1. U0126
    BA2003 U0126
    Summary: A potent, non-ATP-competitive, selective MEK inhibitor
      ≥23.15 mg/mL
  2. SB202190 (FHPI)
    A1632 SB202190 (FHPI)
     19 Citation
    Target: p38
    Summary: MAPK inhibitor
  3. p-Cresyl sulfate potassium
    A9925 p-Cresyl sulfate potassium
    Summary: A potassium form of p-Cresyl sulfate that acts as a pro-inflammatory agent
      ≥2.02 mg/mL
  4. Rehmannioside A
    N2849 Rehmannioside A
    Summary: A steroid glycoside
      Soluble in DMSO
  5. SB-747651A dihydrochloride
    A9983 SB-747651A dihydrochloride
    Summary: A potent ATP-competitive mitogen and stress-activated kinase 1 (MSK1) inhibitor
      Soluble in DMSO
  6. RMC-6236
    A9992 RMC-6236
    Summary: A novel and highly effective inhibitor of RAS(ON) MULTI
      Soluble in DMSO
  7. D-JNKI-1 acetate
    C8595 D-JNKI-1 acetate
    Summary: A cell-permeable JNK peptide inhibitor in the form of acetate
      Soluble in DMSO

7 Items

per page
Relate Categories